Which statement about taking glipizide is concerning to the clinician?

Which statement about taking glipizide is concerning to the clinician?

• A. I may continue to have a glass of wine with dinner.
• B. I should monitor my blood glucose daily.
• C. I will take the medication with breakfast.
• D. Grapefruit juice has no interaction with this drug.

Answer: (A)

Alcohol use with a sulfonylurea like glipizide can trigger dangerous hypoglycemia. Glipizide works by stimulating the pancreas to release insulin, lowering blood glucose. Alcohol impairs the liver’s ability to produce glucose through gluconeogenesis and glycogenolysis, especially if meals are irregular or glycogen stores are low. When these effects overlap, the risk and severity of hypoglycemia increase, which is why the statement about continuing to have a glass of wine with dinner is concerning. Daily blood glucose monitoring is a prudent safety measure when starting glipizide, helping to detect hypoglycemia and assess response. Taking the medication with breakfast aligns with typical dosing and helps prevent hypoglycemia during the day. Grapefruit juice generally does not have a significant interaction with glipizide, so that statement is not a major concern.

Alcohol use with a sulfonylurea like glipizide can trigger dangerous hypoglycemia. Glipizide works by stimulating the pancreas to release insulin, lowering blood glucose. Alcohol impairs the liver’s ability to produce glucose through gluconeogenesis and glycogenolysis, especially if meals are irregular or glycogen stores are low. When these effects overlap, the risk and severity of hypoglycemia increase, which is why the statement about continuing to have a glass of wine with dinner is concerning.

Daily blood glucose monitoring is a prudent safety measure when starting glipizide, helping to detect hypoglycemia and assess response. Taking the medication with breakfast aligns with typical dosing and helps prevent hypoglycemia during the day. Grapefruit juice generally does not have a significant interaction with glipizide, so that statement is not a major concern.